KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-9.54 Cr | ₹7.92 Cr | ₹-15 Cr | ₹-38 Cr | ₹-10 Cr |
What is the latest Cash Flow from Investing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-9.54 Cr |
Mar2023 | ₹7.92 Cr |
Mar2022 | ₹-15 Cr |
Mar2021 | ₹-38 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Investing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-9.54 Cr | Negative | |
Mar2023 | ₹7.92 Cr | Positive | |
Mar2022 | ₹-15 Cr | Negative | |
Mar2021 | ₹-38 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Investing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹558.8 Cr | 0.6% | 10.2% | -4.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 0.6% |
10.2% |
-4.6% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses